If you work in marketing, you can’t escape ChatGPT.
Across my various marketing groups and writer Slacks, it seems like we talk about little else these days. And now it’s showing up in my biopharma feeds, too.
Anyone can see the appeal. Fast, easy and free ideation and content generation? Sounds great!
But, honestly, I’m a ChatGPT skeptic. It can help marketers pump out content quickly, for sure. But in terms of creating meaningful content that reflects your brand voice and highlights your expertise, I think it has a long way to go.
What’s more, I think ChatGPT presents a few unique challenges for biopharma marketers, due to the technical and highly regulated nature of our work. Read on for three of my top concerns — and the role I think AI could play in biopharma content development.
